CIK 0001762303
- Non-accelerated filer
- Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202578762
- Phone
- +1 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-20 | Crowe Suzanne Director | Grant or award | +22,214 | 69,148 | ||
| 2026-01-20 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +16,133 | 16,133 | ||
| 2025-01-21 | Crowe Suzanne Director | Grant or award | +10,022 | 46,934 | ||
| 2025-01-21 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +4,295 | 4,295 | ||
| 2024-12-09 | Crowe Suzanne Director | Purchase | +486 | $13.15 | $6K | 36,912 |
| 2024-06-05 | Crowe Suzanne Director | Grant or award | +9,200 | 36,426 | ||
| 2024-06-05 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +3,943 | 3,943 | ||
| 2023-06-06 | Crowe Suzanne Director | Grant or award | +6,175 | 27,226 | ||
| 2023-06-06 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +2,646 | 2,646 | ||
| 2022-12-12 | Crowe Suzanne Director | Grant or award | +12,589 | 21,051 | ||
| 2022-12-12 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +5,395 | 5,395 | ||
| 2021-12-22 | Crowe Suzanne Director | Grant or award | +4,350 | 8,462 | ||
| 2021-12-22 | Crowe Suzanne Director | Grant or award · Stock Options (Right to Buy) | +2,550 | 2,550 | ||
| 2021-09-20 | Crowe Suzanne Director | Purchase | +1,066 | $17.08 | $18K | 4,112 |
Page 1 of 1 · 14 trades